Last reviewed · How we verify

NCT05414045

Autologous Testicular Tissue Transplantation

Recruiting now NA Last updated 3 April 2025
What this trial tests

NA trial testing Autologous testicular tissue transplantation of prepubertal frozen testicular tissue in Cancer in 5 participants. Currently enrolling.

Timeline
22 November 2024
Primary endpoint
29 July 2030
29 October 2030

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date22 November 2024
Primary completion29 July 2030
Estimated completion29 October 2030
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

Adults 18 to 50, male only, with Cancer or Sickle Cell Thalassemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells (SSCs) in case of imminent gonadotoxic treatment during childhood. In case of total azoospermia in adulthood and presence of a childwish, the investigators intend to perform the first in men autologous testicular tissue transplantation to restore fertility.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05414045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing